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Background: In Western Europe, about 50% of newly diagnosed HIV-positive individuals are diagnosed at a late
stage disease and enter in care late (i.e. with a CD4 count ≤350 μL/μL). The aim of the present study is to analyze
the characteristics and the factors associated with being diagnosed late or at an advanced stage of disease among
persons with a new HIV diagnosis in Italy, in the period 2010–2011.
Methods: We used individual data on new HIV diagnoses reported by the HIV surveillance system in 2010 and in
2011. Persons with CD4 ≤350 cells/μL or diagnosed with AIDS (regardless of the CD4 cell count) were defined as
late presenters (LP); persons with CD4 ≤ 200 cells/μL or AIDS (regardless of the CD4 cell count) were defined as
presenting with advanced HIV disease (AHD).
Results: Of the 7,300 new diagnoses reported in 2010–2011 by the included regions, 55.2% were LP; among these,
37.9% was diagnosed with AIDS. Persons presenting with AHD were 37.8%.
The median age of LP was 40 years (IQR 33–48), significantly higher (p < 0.001) than that of non-LP (35 years); 73.9%
were males; 30.7% were non-nationals. The median age of AHD was 42 years (IQR 35–50), 74.5% were males; 31.1%
were non-nationals.
The proportion of LP among IDUs was 59.8%, among heterosexuals (HET) 61.1% and among MSM 44.3%. The
proportion of AHD among IDUs was 43.6%, among HET 43.2% and among MSM 27.4%.
Factors significantly associated with being LP were: age older than 50 years (OR = 4.6 [95% CI 3.8-5.6]); having been
diagnosed in Southern Italy (Southern vs Northern Italy OR = 1.5 [95% CI 1.3-1.7]) having been diagnosed in Central
Italy (Central vs Northern Italy OR = 1.3 [95% CI 1.1-1.6]); being HET (HET vs MSM, OR = 1.7 [95% CI 1.5-2.0]), being
non-national (Non-national vs Italian, OR 1.7 (95% CI 1.5-2.0); being IDU (IDU vs MSM, OR = 1.6 [95% CI 1.2-2.1]). The
same factors were significantly associated with being AHD.
Conclusions: Older people, people diagnosed in Central and Southern Italy, non nationals, and persons who
acquired the infection through injecting drug use or heterosexual contact showed a higher risk of being diagnosed
late. A more active offer of HIV testing and targeted interventions focussed on these populations are needed to
optimize early access to care and treatment.
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Effective treatment for HIV has been available in Europe
since the mid 1990s and has led to a dramatic reduction
in the incidence of AIDS events and HIV-related deaths.
Many HIV-positive individuals are now living with HIV
as a chronic condition rather than an inevitably fatal
illness.
However, of the approximately 2.3 million HIV-infected
individuals living in the European region, it is estimated
that one in three is unaware of his/her HIV serostatus (i.e.
700,000–900,000 individuals) [1], resulting in significant
levels of late diagnosis and transmission across the region.
In Western Europe, 45–50% of newly diagnosed HIV-
positive individuals are diagnosed and enter care late
(i.e. with a CD4 count ≤350 cells/μL) [2,3].
Late presentation is associated with: increased HIV-
related morbidity and mortality [4-7], shorter survival
[8], poor response to treatment [9,10], increased
healthcare costs [11] and increased rates of HIV trans-
mission [12]. If a person is diagnosed early and HIV
treatment is introduced early in the course of infection
before severe impairment of the immune system has
occurred, life-expectancy may approach that of the
general population [13].
The aim of the present study is to analyze the charac-
teristics and the factors associated with being diagnosed
late or at an advanced stage of disease among persons
newly diagnosed with HIV infection in Italy in 2010 and
2011.
Methods
We used individual data on new HIV diagnoses reported
in Italy in 2010–2011 to the HIV surveillance system.
The HIV surveillance system is coordinated by the
National AIDS Unit of the National Institute of Health
(Rome) and was established in 2008 by a decree of the
Ministry of Health [14] which included HIV infection to
the list of mandatory notifiable infectious diseases.
Individual data on HIV diagnoses reported by clini-
cians are available since 2010. In 2010–2011, 19 out of
21 Italian regions provided individual information on
socio-demographic characteristics, transmission mode,
and CD4 count at HIV diagnosis. These regions account
for 87.5% of the total Italian population. CD4 count was
measured within 15 days after HIV diagnosis.
Persons with CD4 ≤350 cells/μL or diagnosed with
AIDS (regardless of the CD4 cell count) were defined as
late presenters (LP); persons with CD4 ≤ 200 cells/μL or
AIDS (regardless of the CD4 cell count) were defined as
presenting with advanced HIV disease (AHD).
The proportion of LP and AHD was calculated for every
variable; the characteristics of LP and AHD were com-
pared with those of non-LP or non-AHD and differences
were analyzed with the Chi-square test. To comparemedian age we performed statistical analysis using Mann-
Whitney U-test.
Variables included in the univariate analysis were: year
of reporting, gender, age, nationality, area of notification,
transmission mode.
In order to identify factors associated with being LP or
AHD, we built two multivariate logistic regression
models in which being LP or AHD was considered as
dependent variable. Variables with a P value of <0.05
were entered in the model. The fitness of the final model
was assessed with the likelihood ratio test. Gender was
forced into the model regardless of its significance.




Of the 7,300 new HIV diagnoses reported in 2010–2011
by 19 regions, the number of CD4 cell count at HIV
diagnosis was reported for 5,545 persons, of whom 3,059
(55.2%) were LP, and 2,486 non-LP. Among LP, 37.9%
was diagnosed with AIDS.
Among the 3,059 LP, 73.9% were males, 30.7% non-
nationals, 53.3% heterosexuals (HET), 25.7% men who
have sex with men (MSM), 10.3% reported other or un-
determined risk factors, and 6.4% were injecting drug
users (IDU). The median age was 40 years (IQR 33–48)
among LP and 35 years among non-LP (IQR 28–43)
(p <0.000).
One-thousand-eight-hundred-eighty-eight (61.7%) LP
were notified in Northern Italy, 474 (15.5%) in Central
Italy and 697 (22.8%) in Southern Italy.
Among MSM, 44.3% was LP (14.5% had an AIDS
diagnosis, 11.9% was diagnosed with ≤200 cells/μL and
17.9% was diagnosed with 200–350 cells/μL); among
IDU 59.8% was LP (20.1% had an AIDS diagnosis, 22.3%
was diagnosed with ≤200 cells/μL and 17.4% was diag-
nosed with 200–350 cells/μL); among HET 61.1% was
LP (21.9% had an AIDS diagnosis, 19.8% was diagnosed
with ≤200 cells/μL and 19.4% was diagnosed with 200–
350 cells/μL) (Figure 1).
LP, compared to non-LP, underwent HIV testing
because of complaining of clinical conditions associated
with HIV infection (44.0% vs. 16.5%; p-value = 0.000), and
pre-surgery screening (16.9% vs 14.8%; p-value = 0.037).
On the opposite, having engaged in sexual risk behavior
(16.6% vs. 35.0%; p-value = 0.000), being pregnant (3.3% vs
4.3%; p-value = 0.06), having a partner recently found
HIV-positive (2.6% vs 4.1%; p-value = 0.002), and other
parenteral blood exposures (accidental exposure to blood,
syringe exchange) (7.3 vs 14.9; p-value = 0.000) were not
perceived as relevant reasons for undergoing HIV testing.
Factors associated with late presentation were: increas-
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Figure 1 Percent distribution of CD4 counts among new HIV diagnoses by mode of transmission, Italy 2010–2011.
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been exposed to injecting drug use or heterosexual contact
(Table 1).
Advanced HIV disease (AHD)
Among 7,300 new HIV diagnoses reported in 2010–
2011, the number of CD4 cell count at HIV diagnosis
was reported for 5,545 persons, of whom 2,097 (37.8%)
persons presented with AHD. The proportion of males
was 74.5%, 31.1% were non-nationals, 50% were HET,
23.2% were MSM, 10.8% reported other or undetermined
risk factors, and 6.8% were IDU. Among AHD the median
age was 42 years (IQR 34–50), whereas among non-AHD
was 36 (IQR 29–43) (p =0.000).
Among IDUs the proportion of AHD was 43.6%, among
heterosexuals (HET) 43.2% and among MSM 27.4%.
One-hundred-sixty-eight (61.0%) persons with AHD
were reported in Northern Italy, 340 (16.2%) in Central
Italy and 477 (22.8%) in Southern Italy. At multivariate
analysis, the factors associated with AHD were the same
as those found for LP.
Factors significantly associated with being a LP were:
age older than 50 years (OR = 5.8 [95% CI 4.7-7.1]);
having been diagnosed in Southern Italy (Southern vs
Northern Italy OR = 1.4 [95% CI 1.2-1.6]) having been
diagnosed in Central Italy (Central vs Northern Italy
OR = 1.4 [95% CI 1.2-1.6]); being IDU (IDU vs MSM,
OR = 1.8 [95% CI 1.4-2.3]); being HET (HET vs MSM,
OR = 1.7 [95% CI 1.5-2.0]) being non-national (Non-
national vs Italian, OR 1.8(95% CI 1.5-2.0).
Discussion
Our results show that more than half of individuals with a
new HIV diagnosis were LP; among these, more than twothirds were in an advanced stage of HIV disease and one
third was diagnosed with AIDS.
The late HIV diagnosis and the consequent late link-
age to care is a worrying scenario. Indeed, the threshold
below which initiation of ART is strongly recommended
by recent international and Italian guidelines is 350
CD4 cells/uL [15].
The proportion of LP at HIV diagnosis observed in
our study was similar to that reported in other European
countries (Denmark: 55.9%; Germany: 53%; France:
51.9%; United Kingdom: 49.2%; Spain: 45.5%) [1].
In our sample, non-nationals were more likely to be
diagnosed later than Italians, as already reported else-
where [16,17] suggesting a low access to HIV testing
sites, or a poor perception of exposures at risk for HIV,
or the presence of language, cultural or socioeconomic
barriers. However, in Italy HIV testing, care and treat-
ment are provided free-of-charge to both legal and
illegal immigrants.
The median age was significantly higher among LP and
persons with AHD compared to non-LP and non-AHD,
and the probability of being LP or AHD increased with
increasing age, as shown by other Italian studies [16,17].
This finding may be attributed to a lower awareness
among older persons of having been exposed to HIV
infection [18]. Moreover, older persons presenting with
HIV-associated diseases are often misdiagnosed by general
practitioners who may not consider the possibility of HIV
infection in these patients.
Persons reported in Southern and Central Italy were
more likely to be diagnosed late than those reported in
Northern Italy, suggesting a poorer access to HIV testing
centers or a lower risk perception of HIV infection. In the
period 2010–2011 the incidence of new HIV diagnoses
Table 1 Factors associated with being a late presenter among new HIV diagnoses in Italy, 2010-2011
Late presenter Non-late presenter P AOR (95% IC)
No. % row No. % row
Total 3,059 55.2 2,486 44.8
Year of reporting n.s.
2010 1,575 54.0 1,342 46.0
2011 1,484 56.5 1,144 43.5
Gender n.s.
Male 2,261 54.5 1,887 45.5 1
Female 798 57.2 597 42.8 0.9 0.8-1.0
Median age at diagnosis in years (IQR) 40 (33–48) 35 (28–43) 0.000*
Age at diagnosis 0.000**
≤ 29 470 38.9 739 61.1 1
30–34 460 50.7 448 49.3 1.7 1.4-2.1
35–39 509 54.3 429 45.7 2.1 1.7-2.5
40–49 938 61.3 593 38.7 2.9 2.5-3.4
≥ 50 678 71.1 275 28.9 4.6 3.8-5.6
Nationality 0.000**
Italian 2,115 53.1 1,865 46.9 1
Non-national 936 60.4 614 39.6 1,7 1.5-2.0
Area of notification 0.000**
Northern Italy 1,888 53.2 1,658 46.8 1
Centre Italy 474 59.1 328 40.9 1.3 1.1-1.6
Transmission mode 0.000**
MSM 787 44.3 988 55.7 1
IDU 196 59.8 132 40.2 1.6 1.2-2.1
Heterosexual 1,629 61.1 1,037 38.9 1.7 1.5-2.0
Other/not determined 447 57.6 329 42.4 1.6 1.4-2.0
* U Mann-Whitney test.
** Chi2 test.
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pared to that in Central and Northern Italy (South 3.4 per
100,000 Central 5.7 per 100,000, North 6.3 per 100,000).
This finding might have led both health care personnel
and general population to think that the risk of acquiring
HIV infection was actually lower in Southern Italy, thus
minimizing education and information campaigns aimed
at HIV prevention in this area [19].
Despite the strong reduction of the HIV epidemic
among IDU in Italy since 1990 [19], our results evidence
a high proportion of LP and the highest proportion of
persons with AHD among IDU; similar results were
reported in a study conducted in Spain [20]. These find-
ings can be explained by a lower HIV testing uptake in
drug-treatment centers in the last decade [21] mainly
attributable to the decline in HIV prevalence among
IDU [22] and in the number of persons who inject drugs
[21]. These changes may have led healthcare services
to consider the HIV epidemic under control in thispopulation thus reducing the active offer of HIV testing.
This has also caused a minimization of the risk of HIV
infection through unprotected sexual contact among
both injecting and non-injecting drug users [23].
In our study, complaining of clinical conditions associ-
ated with HIV infection was the main reason for undergo-
ing HIV testing among LP, confirming the relevant role of
healthcare professionals (especially general practitioners)
in recommending HIV testing not only in presence of
AIDS-defining diseases but also for specific HIV indicator
conditions [24].
Among LP, having engaged in sexual risk behavior was
not a relevant reason for undergoing HIV testing,
suggesting that unprotected sexual contact is not
perceived as being at risk [25].
IDU and HET had a similar probability of late diagnosis,
higher than that found for MSM. Also other studies
conducted in different countries [18,26] report that MSM
are less likely to be diagnosed late compared to IDU and
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probability among MSM of undergoing HIV testing which
reflects a higher perception of sexual risk behavior [19].
Some weaknesses and strengths of this study need to
be mentioned. In the first place, national data on HIV
surveillance system are available only from 2010. More-
over this study shares the limitation of all surveillance
systems: underreporting, missing data, timelessness and
regional differences in health system.
However, our study has several advantages: it provides a
picture of both LP and AHD for two recent years, is based
on a robust sample of individuals, has an almost-national
geographical coverage, offers information on the testing
attitude of individuals exposed to HIV infection based on
the reasons for HIV testing.
Conclusions
Despite the recommendation for initiating ART early, in
Italy the interventions to discover hidden HIV cases are
few and the proportion of LP is quite high. In this study,
more than half of new HIV diagnoses are LP, mainly
persons older than 50 years of age, non-nationals,
persons living in Central-Southern Italy, and persons
who acquired the infection through injecting drug use
or heterosexual contact. These results reinforce the
importance of identifying HIV infection as early as
possible and suggest the need for a more active offer of
HIV testing in these groups. The presence of HIV-
related symptoms represents an effective trigger for
early diagnosis; general practitioners play a crucial role
in the early identification of HIV-infected individuals
and should consider HIV infection even among older
individuals, encouraging HIV testing when appropriate.
At-risk sexual behavior instead is not recognized as a
sufficient reason for being tested. An effort to improve
the awareness of exposures at risk is required, to
optimize the early linkage to care and treatment, and to
reduce HIV morbidity, mortality and transmission.
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